IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.

K Ljunggren, PA Broliden… - Clinical and …, 1988 - ncbi.nlm.nih.gov
K Ljunggren, PA Broliden, L Morfeldt-Månson, M Jondal, B Wahren
Clinical and experimental immunology, 1988ncbi.nlm.nih.gov
The anti-HIV IgG subclass response was analysed in sera from different clinical stages and
related to virus specific antibody-dependent cellular cytotoxicity (ADCC). IgG1 was found to
be the dominant subclass, present in all sera and with similar mean titres at different stages.
The number of anti-HIV IgG3 positive sera, measured on whole viral lysate antigen plates,
decreased during disease progression from 38% in symptom-free to 7% in AIDS patients.
IgG2 and IgG4 subclasses were less prevalent although a slight increase of IgG4 frequency …
Abstract
The anti-HIV IgG subclass response was analysed in sera from different clinical stages and related to virus specific antibody-dependent cellular cytotoxicity (ADCC). IgG1 was found to be the dominant subclass, present in all sera and with similar mean titres at different stages. The number of anti-HIV IgG3 positive sera, measured on whole viral lysate antigen plates, decreased during disease progression from 38% in symptom-free to 7% in AIDS patients. IgG2 and IgG4 subclasses were less prevalent although a slight increase of IgG4 frequency was found in AIDS patients. High IgG1 titres correlated with a positive ADCC reaction but there was no correlation between anti-HIV IgG1 and ADCC titres. Some sera which contained HIV IgG1 as the only subclass were able to mediate an ADCC reaction. In addition, when anti-HIV IgG3 was isolated, by protein A chromatography, no ADCC killing was induced by these antibodies. It is concluded that IgG1 is the major ADCC-active IgG subclass in HIV infected individuals. The lack of correlation between IgG1 and ADCC titres may be explained by a relatively small fraction of IgG1 antibodies mediating ADCC.
ncbi.nlm.nih.gov